We are live on ! Find out more
EFM

EQT Fund Management Portfolio holdings

AUM $863M
1-Year Est. Return 26.03%
This Fund
S&P 500
This Quarter Est. Return
-12.66%
1 Year Est. Return
-26.03%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$863M
AUM Growth
-$158M
Cap. Flow
+$32.2M
Cap. Flow %
3.73%
Top 10 Hldgs %
100%
Holding
5
New
Increased
2
Reduced
Closed

Top Buys

Rank Stock Value
1
OCS icon
Oculis Holding
OCS
+$23.8M
2
EVMN
Evommune Inc
EVMN
+$8.33M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAY
1
Waystar Holding Corp
WAY
$4.73B
$511M 59.21%
24,879,437
PHVS icon
2
Pharvaris
PHVS
$2.47B
$118M 13.73%
3,424,609
OCS icon
3
Oculis Holding
OCS
$731M
$96.4M 11.18%
6,950,294
+1,050,000
+18% +$23.8M
EVMN
4
Evommune Inc
EVMN
$516M
$70.3M 8.15%
5,288,313
+358,680
+7% +$8.33M
AGMB
5
AgomAb Therapeutics NV
AGMB
$668M
$66.7M 7.74%
5,141,992

Similar funds

EQT Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, EQT Fund Management held 5 positions worth $863M, down 15% from $1.02B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

EQT Fund Management deployed $32.2M of net new capital in Q2 2026, adding to 2 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • EQT Fund Management added most to Oculis Holding in Q2 2026, an estimated $23.8M increase.
  • EQT Fund Management's ten largest holdings make up 100% of its $863M portfolio in Q2 2026.
  • EQT Fund Management opened 0 new positions and closed 0 in Q2 2026.
  • EQT Fund Management's portfolio value fell 15% quarter-over-quarter to $863M.

Based on EQT Fund Management's 13F filing for Q2 2026, filed 13 Aug 2026.